Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator

Journal of Clinical Investigation

Volumn 97, Issue 11, 1996, Pages 2440-2451

  Yamamoto, Koji ^a   Loskutoff, David J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

endotoxemia; gene expression; plasminogen activator inhibitor 1; thrombosis; tissue factor

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; ENDOTOXIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; FIBRIN; MESSENGER RNA; OLIGONUCLEOTIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; FIBRIN DEPOSITION; FIBRINOLYSIS; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEPSIS; TISSUE DISTRIBUTION; TISSUE SPECIFICITY;

EID: 0029888356     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118691     Document Type: Article

References (59)

1. Cybulsky, M.I., M.K.W. Chan, and H.Z. Movat. 1988. Biology of disease: acute inflammation and microthrombosis induced by endotoxin, interleukin-1, and tumor necrosis factor and their implication in gram-negative infection. Lab. Invest. 58:365-378.
2. Kincaid-Smith, P., and J.A. Whitworth. 1989. Disseminated intravascular coagulation and the kidney. In Hemostasis and the Kidney. Butterworth & Co., London. 191-198.
3. Coalson, J.J. 1986. Pathology of sepsis, septic shock, and multiple organ failure. In Perspective on Sepsis and Septic Shock. Society of Critical Care Medicine, Fullerton, CA. 27-59.
4. Morrison, D.C., and J.L. Ryan. 1987. Endotoxins and disease mechanisms. Annu. Rev. Med. 38:417-432.
5. Moore, K.L., S.P. Andreoli, N.L. Esmon, C.T. Esmon, and N.U. Bang. 1987. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J. Clin. Invest. 79:124-130.
6. Edgington, T.S., N. Mackman, K. Brand, and W. Ruf. 1991. The structural biology of expression and function of tissue factor. Thromb. Haemostasis. 66:67-79.
7. Broze, G.J., Jr. 1982. Binding of human Factor VII and VIIa to monocytes. J. Clin. Invest. 70:526-535.
8. Gregory, S.A., J.H. Morrissey, and T.S. Edgington. 1989. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol. Cell. Biol. 9:2752-2755.
9. Crossman, D.C., D.P. Carr, E.G.D. Tuddenham, J.D. Pearson, and J.H. McVey. 1990. The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. J. Biol. Chem. 265:9782-9787.
10. Osterud, B., and T. Flaegstad. 1983. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection related to an unfavorable prognosis. Thromb. Haemostasis. 49:5-7.
11. Warr, T.A., L.V.M. Rao, and S.I. Rapaport. 1990. Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity. Blood. 75:1481-1489.
12. Drake, T.A., J. Cheng, A. Chang, and F.B. Taylor. Jr. 1993. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am. J. Pathol. 142:1458-1470.
13. Mackman, N., M.S. Sawdey, M.R. Keeton, and D.J. Loskutoff. 1993. Murine tissue factor gene expression in vivo: tissue and cell specificity and regulation by lipopolysaccharide. Am. J. Pathol. 143:76-84.
14. Vassalli, J.D., A. Sappino, and D. Belin. 1991. The plasminogen activator/plasmin system. J. Clin. Invest. 88:1067-1072.
15. Dano, K., P.A. Andreasen, J. Grondahl-Hansen, P. Kristensen, L.S. Nielsen, and L. Skriver. 1985. Plasminogen activators, tissue degradation, and cancer. Adv. Cancer Res. 44:139-266.
16. Kristensen, P., L.I. Larsson, L.S. Nielsen, J. Grondahl-Hansen, P.A. Andreasen, and K. Dano. 1984. Human endothelial cells contain one type of plasminogen activator. FEBS Lett. 168:33-37.
17. Hoylaerts, M., D.C. Rijken, H.R. Lijnen, and D. Collen. 1982. Kinetics of the activation of plasminogen by human tissue plasminogen activator: role of fibrin. J. Biol. Chem. 257:2912-2919.
18. Collen, D., and H.R. Lijnen. 1991. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood. 78:3114-3124.
19. Vassalli, J.-D., J.-M. Dayer, A. Wohlwend, and D. Belin. 1984. Concomitant secretion of prourokinase and of a plasminogen activator-specific by cultured human monocytes-macrophages. J. Exp. Med. 159:1653-1668.
20. 1 55,000 form of the human plasminogen activator, urokinase. J. Cell Biol. 100:86-92.
21. Blasi, F., J. Vassalli, and K. Dano. 1987. Urokinase-type plasminogen activator. Proenzyme, receptor, and inhibitors. J. Cell Biol. 104:801-804.
22. Loskutoff, D.J., M. Sawdey, and J. Mimuro. 1988. Type 1 plasminogen activator inhibitor. In Progress in Hemostasis and Thrombosis. B. Coller, editor. W.B. Saunders Co., Philadelphia. 87-115.
23. Hamsten, A., B. Wiman, U. deFaire, and M. Blomback. 1985. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N. Engl. J. Med. 313:1557-1563.
24. Tabernero, M.D., A. Estélles, V. Vicente, I. Alberca, and J. Aznar. 1989. Incidence of increased plasminogen activator inhibitor in patients with deep venous thrombosis and/or pulmonary embolism. Thromb. Res. 56:565-570.
25. Quax, P.H.A., C.M. van den Hoogen, J.H. Verheijen, T. Padro, R. Zeheb, T.D. Gelehrter, T.J.C. van Berkel, J. Kuiper, and J.J. Emeis. 1990. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo. J. Biol. Chem. 265:15560-15563.
26. Sawdey, M.S., and D.J. Loskutoff. 1991. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-α, and transforming growth factor-β. J. Clin. Invest. 88:1346-1353.
27. Fearns, C., T. Thinnes, K. Roegner, and D.J. Loskutoff. 1993. Kinetics of induction of PAI-1 gene expression on liver endothelial cells and hepatocytes by lipopolysaccharide (LPS). Thromb. Haemostasis. 69:757a. (Abstr.)
28. Saldeen, T. 1970. The importance of intravascular coagulation and inhibition of the fibrinolytic system in experimental fat embolism. J. Trauma. 10: 287-298.
29. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
30. Rickles, R.J., A.L. Darrow, and S. Strickland. 1988. Molecular cloning of complementary DNA to mouse tissue plasminogen activator mRNA and its expression during F9 teratocarcinoma cell differentiation. J. Biol. Chem. 263: 1563-1569.
31. Belin, D., J.-D. Vassalli, C. Combepine, F. Godeau, Y. Nagamine, E. Reich, H.P. Kocher, and R.M. Duvosin. 1985. Cloning, nucleotide sequencing and expression of cDNAs encoding mouse urokinase-type plasminogen activator. Eur. J. Biochem. 148:225-232.
32. Prendergast, G.C., L.E. Diamond, D. Dahl, and M.D. Cole. 1990. The c-myc-regulated gene mrl encodes plasminogen activator inhibitor 1. Mol. Cell. Biol. 10:1265-1269.
33. Mackman, N., S. Imes, W.H. Maske, B. Taylor, A.J. Lusis, and T.A. Drake. 1992. Structure of the murine tissue factor gene. Chromosome location and conversation of regulatory elements in the promoter. Arterioscler. Thromb. 12:474-483.
34. Derynck, R., J.A. Jarrett, E.Y. Chen, and D.V. Goeddel. 1986. The murine transforming growth factor-β precursor. J. Biol. Chem. 261:4377-4379.
35. Seiffert, D., M. Keeton, Y. Eguchi, M. Sawdey, and D.J. Loskutoff. 1991. Detection of vitronectin mRNA in tissues and cells of the mouse. Proc. Nad. Acad. Sci. USA. 88:9402-9406.
36. Nichols, W.C., K.A. Cooney. K.L. Mohlke, J.D. Ballew, A. Yang, M.E. Bruck, M. Reddington, E.K. Novak, R.T. Swank, and D. Ginsberg. 1994. von Willebrand disease in the RIIIS/J mouse is caused by a defect outside of the von Willebrand factor gene. Blood. 83:3225-3231.
37. Tokunaga, K., H. Taniguchi, K. Yoda, M. Shimizu, and S. Sakiyama. 1986. Nucleotide sequence of a full-length cDNA for mouse cyloskeletal β-actin mRNA. Nucleic Acids Res. 14:2829.
38. Baldwin, G.S., and Q.-X. Zhang. 1992. Measurement of gastrin and transforming growth factor a messenger RNA levels in colonic carcinoma cell lines by quantitative polymerase chain reaction. Cancer Res. 52:2261-2267.
39. Wang, A.M., M.V. Doyle, and D.F. Mark. 1989. Quantitation of mRNA by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA. 86:9717-9721.
40. Samad, F., K. Yamamoto, and D.J. Loskutoff. 1996. Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-α and lipopolysaccharide. J. Clin. Invest. 97: 37-46.
41. Keeton, M., Y. Eguchi, M. Sawdey, C. Ahn, and D.J. Loskutoff. 1993. Cellular localization of type 1 plasminogen activator inhibitor mRNA and protein in murine renal tissue. Am. J. Pathol. 142:59-70.
42. Suffredini, A.F., P.C Harpel, and J.E. Parrillo. 1989. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N. Engl. J. Med. 320:1165-1172.
43. van Deventer, S.J.H., H.R. Buller, J.W. ten Cate, L.A. Aarden, C.E. Hack, and A. Sturk. 1990. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood. 76:2520-2526.
44. McNicol, G.P., A.P. Fletcher, N. Alkjaersig. and S. Sherry. 1962. The absorption, distribution and excretion of epsilon-aminocaproic acid following oral or intravenous administration to man. J. Lab. Clin. Med. 59:15-21.
45. Murray, L.J., R. Lee, and C. Martens. 1990. In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp-lpr/lpr mouse. Eur. J. Immunol. 20:163-170.
46. Platzer, C., G. Richter, K. Überla, W. Müller, H. Blöcker, T. Diamantstein, and T. Blankenstein. 1992. Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase chain reaction. Eur. J. Immunol. 22:1179-1184.
47. Rickles, R.J., and S. Strickland. 1988. Tissue plasminogen activator mRNA in murine tissues. FEBS Lett. 229:100-106.
48. Almus-Jacobs, F., N. Varki, M.S. Sawdey, and D.J. Loskutoff. 1995. Endotoxin stimulates murine urokinase-type plasminogen activator receptor gene expression in vivo. Am. J. Pathol. 147:688-698.
49. Kreger, B., D. Craven, and W. McCabe. 1980. Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am. J. Med. 68:344-355.
50. Carmeliet, P., J.M. Stassen, L. Schoonjans, B. Ream, J.J. Van den Oord, M. De Mol, R.C. Mulligan, and D. Collen. 1993. Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis. J. Clin. Invest. 92:2756-2760.
51. Moll, S., J.A. Schifferli, J. Huarte, R. Lemoine, J.-D. Vassalli, and A.-P. Sappino. 1994. LPS induces major changes in the extracellular proteolytic balance in the murine kidney. Kidney Int. 45:500-508.
52. McGehee, W.G., S.I. Rapaport, and P.F. Hjort. 1967. Intravascular coagulation in fluminant meningococcemia. Ann. Intern. Med. 67:250-260.
53. Shimamura, K., K. Oka, M. Natazawa, and M. Kojima. 1983. Distribution patterns of microthrombi in disseminated intravascular coagulation. Arch. Pathol. Lab. Med. 107:543-547.
54. Craane, H., J.J. Emeis, J. Lindeman, and W. Nieuwenhuizen. 1978. Immunoenzymehistochemical detection of fibrin microthrombi during disseminated intravascular coagulation in rats. Histochemistry. 57:97-105.
55. Carmeliet, P., L. Schoonjans, L. Kieckens, B. Ream, J. Degen, R. Bronson, R. De Vos, J.J. Van den Oord, D. Collen, and R.C. Mulligan. 1994. Physiological consequences of loss of plasminogen activator gene function in mice. Nature (Lond.). 368:419-424.
56. Charytan, C., and D. Purtilio. 1969. Glomerular capillary thrombosis and acute renal failure after epsilon-amino caproic acid therapy. N. Engl. J. Med. 280:1102-1104.
57. Vassalli, J.-D., J. Huarte, D. Belin, P. Guhler, A. Vassalli, M.L. O'Connell, L.A. Parton, R.J. Rickles, and S. Strickland. 1989. Regulated polyadenylation controls mRNA translation during meiotic maturation of mouse oocytes. Genes & Dev. 3:2163-2171.
58. Rapaport, S.I. 1991. Regulation of the tissue factor pathway. Ann. NY Acad. Sci. 614:51-62.
59. Creasey, A.A., A.C.K. Chang, L. Feigen, T.-C. Wün. F.B. Taylor, Jr., and L.B. Hinshaw. 1993. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J. Clin. Invest. 91:2850-2860.